Sort   by:  
 Page size 
UnknownA panel of ancestry informative markers to estimate and correct potential effects of population stratification in Han Chinese.
Not available
S-EPMC3895631 | biostudies-literature
UnknownGenomic dissection of population substructure of Han Chinese and its implication in association studies.
Not available
S-EPMC2790582 | biostudies-literature
UnknownRisk prediction for breast Cancer in Han Chinese women based on a cause-specific Hazard model.
Not available
S-EPMC6367757 | biostudies-literature
UnknownAssociation study of the β2-adrenergic receptor gene polymorphisms and hypertension in the Northern Han Chinese.
Not available
S-EPMC3071737 | biostudies-literature
TranscriptomicsChemotherapy plus EGFR-TKI as first-line treatment provides better survival for advanced EGFR positive lung adenocarcinoma patients: updated data and exploratory in vitro study
To probe into the potential mechanisms contributing to the strong synergistic interaction between gefitinib and pemetrexed, gene expression profiles of PC-9 cells exposed to gefitinib, pemetrexed or combined treatment were analyzed using microarray technique.
ORGANISM(S): Homo sapiens 
2020-03-12 | E-MTAB-8661 | biostudies-arrayexpress
UnknownAssociation of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients.
Not available
S-EPMC4230134 | biostudies-literature
ProteomicsProteomic analysis of NSD3 isoforms in prostate cancer cells Dataset1
Identify interacting proteins for the protein of interest before and after DNA damage.
ORGANISM(S): Homo sapiens (Human) 
2026-06-29 | PXD060291 | Pride
Dna damage 
ProteomicsProteomic analysis of NSD3 isoforms in prostate cancer cells Dataset2
Identify interacting proteins for the protein of interest before and after DNA damage.
ORGANISM(S): Homo sapiens (Human) 
2026-06-29 | PXD060288 | Pride
Dna damage 
UnknownSTING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.
Not available
S-EPMC10036562 | biostudies-literature
UnknownQuadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial.
Not available
S-EPMC10078362 | biostudies-literature
Sort   by:  
 Page size